MOMarco Edmundo Ordoñez-Linares

Marco Edmundo Ordoñez-Linares

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marco Edmundo Ordoñez-Linares has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Variantes en el número de copias y consanguinidad parental en neonatos de altura con anomalías congénitas en Perú

    by Hugo Hernán Abarca Barriga, Felix Chavesta Velásquez, Claudia Barletta Carrillo, Abel Paucarmayta Tacuri, Margaret Bazán Hurtado, Tania Vásquez Loarte, Luis Ordoñez Rondón, Marco Ordoñez Linares, Evelina Andrea Rondón Abuhadba

    Introducción. Las variantes en el número de copias son un tipo de cambios en el genoma provocan anomalías congénitas. Objetivo. Determinar las variantes en el número de copias y el grado de consanguinidad parental en neonatos con síndromes malformativos o una anomalía congénita mayor asociado a dismorfia facial o hipotonía. Material y métodos. Se realizó el análisis cromosómico por micromatrices a 60 neonatos con anomalías congénitas evaluados en los Hospitales Antonio Lorena y Regional de Cusco. Resultados. Del total de pacientes estudiados, el 70% tuvo un resultado anómalo; de los cuales en el 14,2% de los recién nacidos se encontraron variantes en el número de copias patogénicas o probablemente patogénicas asociadas o no a regiones de homocigosidad que tuvieron relación con las anomalías congénitas descritas. En el 48,3% de los recién se encontró regiones de homocigosidad mayores a 0,5% (coeficiente de endogamia superior a 1/64). Por otro lado, encontramos cinco variantes en el número de copias de patogenicidad desconocida que no se han descrito anteriormente y podrían estar relacionadas con el fenotipo. Conclusiones. Nuestra tasa de detección de las variantes en el número de copias está en relación con los reportes internacionales previos. Sin embargo, el porcentaje de neonatos con consanguinidad parental se encuentra por encima de lo reportado previamente, siendo superior a otras regiones de Sudamerica. Este es el primer reporte en el Perú, y es pionero en Latinoamérica al utilizar el análisis cromosómico por micromatrices en esta cohorte específica de pacientes.


  • Open Access

    Characterization of coronavirus disease 2019 (COVID-19) in children and adolescents in Latin American and the Caribbean countries: A descriptive study

    by Noé Atamari-Anahui, Nelson Deyvis Cruz-Nina, Mirian Condori-Huaraka, Héctor Nuñez-Paucar, Evelina Andrea Rondón-Abuhadba, Marco Edmundo Ordoñez-Linares, César Johan Pereira-Victoriod

    Coronavirus disease 2019 has been reported in the pediatric population; however, there is limited information in Latin American and the Caribbean countries. To describe the frequency of cases, deaths, incidence, and case fatality rate attributed to COVID-19 in children and adolescents from Latin American and the Caribbean countries. An observational study was carried-out using COVID-19 case registries in children and adolescents published by the Ministries of Health of 19 countries in Latin American and the Caribbean countries until May 20, 2020. Cases and deaths were classified by sex and age group. Also, incidence and case fatality rates were calculated for each country. A total of 20,757 (4.2% of all patients) cases of COVID-19 were reported in children from 0 to 19 years of age. 52.4% was in the group aged 10 to 19 years. 50.6% were male. 139 (0.26%) deaths were reported in children from 0 to 19 years. The accumulated incidence was higher in Chile, Panama, and Peru. The cumulative incidence per 100,000 inhabitants ranged from 1.26 to 77.55 in the population from 0 to 9 years old, 1.57 to 98.84 from 10 to 19 years old, and 0.91 to 88.34 from 0 to 19 years old. The case fatality rate in children from 0 to 19 years old ranged from 0 to 9.09%. In 19 Latin American and the Caribbean countries, the frequency of cases, cumulative incidence, case fatality rate in children and adolescents was heterogeneous. These results contribute to understanding the epidemiological behavior of this disease in children and adolescents of the countries included in the study.


  • Open Access

    Pulmonary actinomycosis in children: report of two Peruvian cases

    by Héctor Nuñez-Paucar, Carlos Valera-Moreno, Mariela Katherine Zamudio-Aquise, Fabio Pérez-Garfias, Eduardo Jesús Guzmán-Quispe, Carlo Calizaya-Gallegos, Maycol Suker Ccorahua-Rios, Ana Claudia Santander-Cahuantico, Marco Edmundo Ordoñez-Linares, Noé Atamari-Anahui

    Introduction Actinomycosis is a rare infectious disease caused by Gram-positive bacteria. The most common species is Actinomyces israelii. Among its forms of presentation, the thoracic is the least frequent. Case presentation We report two patients with thoracic actinomycosis, 8 and 13 years old, from different geographical areas of Peru. The first case had empyema necessitans and the second, lung consolidation and recurrent hemoptysis. Both had a certain degree of difficulty in their diagnosis but responded favorably to antibiotics and surgical treatment. The diagnosis was based on the histopathological study. However, we were not able to ascertain the species of actinomyces. Conclusion Thoracic actinomycosis is rare in children and presents as a parenchymal lesion with possible fistulization to the chest wall. This article is one of the few in the Peruvian literature, constituting a contribution to the knowledge of the disease and its management in pediatrics.


  • Peruvian Newborn Male with 3p13 Deletion Syndrome Encompassing the FOXP1 Gene: Review of the Literature

    by Hugo H. Abarca-Barriga, Milana Trubnykova, Félix Chavesta-Velásquez, Claudia Barletta-Carrillo, Marco Ordoñez-Linares, Andrea Rondón-Abuhadba

    Copy number variation in loss of 3p13 is an infrequently reported entity characterized by hypertelorism, aniridia, microphthalmia, high palate, neurosensorial deafness, camptodactyly, heart malformation, development delay, autism spectrum disorder, seizures, and choanal atresia. The entity is caused probably by haploinsufficiency for FOXP1, UBA3, FAM19A1, and MITF. We report a newborn male with hypotonia, facial dysmorphism, heart malformation, and without clinical diagnosis; nevertheless, the use of appropriate genetic test, such us the chromosomal microarray analysis allowed identification of a copy number variant in loss of 5.5 Mb at chromosome 3 (p13-p14.1), that included 54 genes, encompassing FOXP1 gene. We compare the findings in our Peruvian patient to those of earlier reported patients; furthermore, add new signs for this entity.


  • Open Access

    Association between hospitalization stay and diabetic foot: an analytical cross-sectional study in three Peruvian hospitals

    by Christian R. Mejia, Liz Paucar-Tito, Luz Morales-Concha, Noé Atamari-Anahui, Evelina Andrea Rondón-Abuhadba, Marco Edmundo Ordoñez-Linares

    Introduction Diabetic foot is one of the main complications of diabetes mellitus; however, in hospitals of provinces from Peru, the relationship of this condition with hospital stay has not been calculated. Objective To determine the association between hospitalization time and diabetic foot in three hospitals from Cusco, Peru. Methods A cross-sectional study of secondary data analysis was conducted. We analyzed the data of patients with type 2 diabetes mellitus admitted to the internal medicine service between January and December 2016, in three tertiary hospitals in Cusco, Peru. Correlation coefficients and p-values were calculated using generalized linear models, with Gaussian family and identity function, adjusted by intervening variables. Values of p < 0.05 were considered statistically significant. Results Of the 153 patients, 14% (21) had a diabetic foot diagnosis, and their median age was 61 years (interquartile range 56 to 68). Those who had a diabetic foot had on average 20 hospitalization days. A strong association was found between a diabetic foot and the number of hospitalization days (17 days more, p = 0.003); adjusted by six variables. Those patients with a history of hypertension had more hospitalization days (10 days more, p = 0.011) and those admitted to a hospital of the Ministry of Health, had fewer hospitalization days (10 days less, p = 0.032). Conclusion The group of patients with diabetic foot had a longer hospitalization time. The longer hospitalization time could be due to complications of the disease or difficulties in management.